Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.3822
+0.0031 (0.82%)
At close: Feb 11, 2026
Avaí Bio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 276.32K | -644.98K | -70.01% |
| Mar 31, 2022 | 921.31K | -292.80K | -24.12% |
| Mar 31, 2021 | 1.21M | 496.66K | 69.23% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Latch | 66.49M |
| Investview | 40.97M |
| ConnectM Technology Solutions | 32.48M |
| Triller Group | 27.48M |
| PAID, Inc. | 20.69M |
| CreditRiskMonitor.com | 20.08M |
| Ankam | 310.61K |
| Transuite.Org | 115.00K |
Avaí Bio News
- 16 days ago - Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium - PRNewsWire
- 2 months ago - Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment - PRNewsWire
- 2 months ago - Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival - PRNewsWire
- 2 months ago - Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival - Business Wire
- 2 months ago - THE CRITICAL LIST: 5 Stocks Anchoring the New Economy - GlobeNewsWire
- 3 months ago - Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies - Business Wire
- 3 months ago - Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment - Business Wire
- 4 months ago - Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho - PRNewsWire